Cerebral venous sinus thrombosis in the covid-19 pandemic

Chaitanya B. Medicherla, Rachel A. Pauley, Adam de Havenon, Shadi Yaghi, Koto Ishida, Jose L. Torres*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

Background: Recent studies have noted concern for increased thromboembolic events in the setting of Coronavirus Disease 2019 (COVID-19). Cerebral venous sinus thrombosis (CVST) is a form of thromboembolism that has been observed as a neuro-ophthalmologic complication of COVID-19. Methods: Review of the scientific literature. Results: In this article, we report an overview of CVST epidemiology, clinical presentation, diagnostics, disease pathophysiology, and management in the setting of COVID-19. Conclusion: CVST is an uncommon thromboembolic event with variable phenotypes and multiple etiologies. Neurologic complications can be severe, including significant visual deficits and death. Current observations suggest that the risk of CVST may be profoundly impacted by this novel COVID-19 pandemic, thus prompting increased attention to disease presentation, pathogenesis, and management.

Original languageEnglish (US)
Pages (from-to)457-462
Number of pages6
JournalJournal of Neuro-Ophthalmology
Volume40
Issue number4
DOIs
StatePublished - 2020

ASJC Scopus subject areas

  • Ophthalmology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Cerebral venous sinus thrombosis in the covid-19 pandemic'. Together they form a unique fingerprint.

Cite this